Journal profile · Dermatology
Photodermatology Photoimmunology & Photomedicine
ISSN 0905-4383 · eISSN 1600-0781 · Blackwell Munksgaard · DENMARK · Bimonthly · Founded 1990
Photodermatology Photoimmunology & Photomedicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.72; hybrid open access; APC about USD 4,550; median 120 days to acceptance (89 articles, last 24 months); community-reported acceptance: fairly easy; 85 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Photodermatology Photoimmunology & Photomedicine is published by Blackwell Munksgaard and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Skin Protection and Aging, Photodynamic Therapy Research Studies and melanin and skin pigmentation, together about 45.7% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)
The journal is a forum for new information about the direct and distant effects of electromagnetic radiation (ultraviolet, visible and infrared) mediated through skin. The divisions of the editorial board reflect areas of specific interest: aging, carcinogenesis, immunology, instrumentation and optics, lasers, photodynamic therapy, photosensitivity, pigmentation and therapy. Photodermatology, Photoimmunology & Photomedicine includes original articles, reviews, communications and editorials. Original articles may include the investigation of experimental or pathological processes in humans or animals in vivo or the investigation of radiation effects in cells or tissues in vitro. Methodology need have no limitation; rather, it should be appropriate to the question addressed.
Source: LetPub
Research area (LetPub): Dermatology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Skin Protection and AgingMedicine28.8%
- Photodynamic Therapy Research StudiesMedicine8.6%
- melanin and skin pigmentationBiochemistry, Genetics and Molecular Biology8.3%
- Nonmelanoma Skin Cancer StudiesMedicine7.8%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology7%
- Dermatologic Treatments and ResearchMedicine6.2%
- Dermatology and Skin DiseasesMedicine4.9%
- Acne and Rosacea Treatments and EffectsMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.72LetPub ·
- CiteScore 2026-06
- 5.4LetPub ·
- SJR 2026-06
- 0.84LetPub ·
- SNIP 2026-06
- 0.98LetPub ·
- h-index
- 56LetPub ·
- h-index
- 82OpenAlex ·
- i10-index
- 1,096OpenAlex ·
- 2-year mean citedness
- 2.47OpenAlex ·
- Self-citation rate
- 3.7%LetPub ·
- Share of gold OA articles
- 26.32%LetPub ·
Volume
- Articles per year
- 51LetPub ·
Articles by year OpenAlex count · 2,499 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 23 | 10 |
| 2025 | 85 | 51 | 171 |
| 2024 | 81 | 47 | 362 |
| 2023 | 92 | 52 | 522 |
| 2022 | 97 | 18 | 652 |
| 2021 | 122 | 42 | 1,190 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
120 daysMedian, submission to acceptance · P25–P75 80 days – 178 days
- Acceptance to online
- median 14 days (89 articles)
- Submission to online
- median 140 days
- Sample
- 89 articles with submission and acceptance dates (146 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,550 / EUR 3,810 / GBP 3,020 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Blackwell Munksgaard
- Country or region
- DENMARK
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1990
- ISSN
- 0905-4383
- Electronic ISSN
- 1600-0781
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Photodermatology Photoimmunology & Photomedicine
What CAS zone is Photodermatology Photoimmunology & Photomedicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Photodermatology Photoimmunology & Photomedicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Dermatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Photodermatology Photoimmunology & Photomedicine?
The latest impact factor listed by LetPub is 2.72; CiteScore 5.4, h-index 82.
How long does peer review take at Photodermatology Photoimmunology & Photomedicine?
Based on the dates recorded on 89 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 120 days (interquartile range 80–178 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Photodermatology Photoimmunology & Photomedicine?
According to LetPub and DOAJ records, Photodermatology Photoimmunology & Photomedicine is indexed in SCIE and Scopus.
Is Photodermatology Photoimmunology & Photomedicine open access, and what is the APC?
Photodermatology Photoimmunology & Photomedicine is a hybrid journal. For open-access publication: APC about USD 4,550.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .